SCHEMBL8332136

SCHEMBL8332136

CCc1ccc(Br)c(N=C(N)N)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.52
SIGMAR1 Q99720 12/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HTT P42858 2/20 0.43
MEN1 O00255 1/20 0.43
RAD52 P43351 1/20 0.43
KMT2A Q03164 1/20 0.43
NOS3 P29474 2/20 0.39
NOS1 P29475 2/20 0.39
NOS2 P35228 2/20 0.39
TRPA1 O75762 1/20 0.38
ADRA2A P08913 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
GRIN2D O15399 2/20 0.37
GRIN3B O60391 2/20 0.37
GRIN1 Q05586 2/20 0.37
GRIN2A Q12879 2/20 0.37
GRIN2B Q13224 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6727713 0.77 SIGMAR1 (0.70) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL7211128 0.76 SIGMAR1 (0.72) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL11877875 0.75 PLAU (0.50) PLAUSIGMAR1RAD52NOS3NOS1
Hydrochloric Acid SCHEMBL7205189 0.75 SIGMAR1 (0.82) SIGMAR1MEN1KMT2AMAPT
SCHEMBL6716818 0.72 SIGMAR1 (0.59) SIGMAR1MEN1KMT2AGRIN2DGRIN3B
SCHEMBL11879382 0.72 HTR3E (0.47) PLAUALDH1A1ADRA2AADRA2BADRA2C
Hydrochloric Acid SCHEMBL9045265 0.71 PLAU (0.43) PLAUSIGMAR1NOS3NOS1NOS2
SCHEMBL4798301 0.69 TRPA1 (0.46) SMN1; SMN2ALDH1A1NOS3NOS1NOS2
SCHEMBL28277786 0.69 RAB9A (0.49) SMN1; SMN2ALDH1A1HTTTRPA1KDM4E
SCHEMBL10208289 0.69 TRPA1 (0.64) SMN1; SMN2ALDH1A1TRPA1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999002145-A1 COMBINATION DRUG THERAPIES COMPRISING AMINOGLYCOSIDE ANTIBIOTICS AND N,N'-DISUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-01-21 WO disclosed